As the Democratic Republic of the Congo (DRC) responds to a Bundibugyo Ebola outbreak, the Global Virus Network (GVN) brought together frontline outbreak leaders from the DRC, the World Health Organization (WHO), Africa CDC, and GVN Centers of Excellence to discuss the evolving outbreak, ongoing response efforts, diagnostic challenges, and implications for regional and global health security. Experts provided firsthand updates from the field, discussed surveillance and contact tracing efforts, highlighted the importance of community engagement and trust, examined challenges associated with diagnosing and responding to Bundibugyo Ebola, and explored priorities for therapeutics, vaccines, outbreak preparedness, and international coordination.
Watch video
Senior Scientist at the Centre for the AIDS Programme of Research in South Africa (CAPRISA) and Also a Site Co-Principal Investigator for the Purpose 1 clinical trial - which contributed to the evidence base underpinning lenacapavir and reported the landmark efficacy findings that have generated so much interest globally, Dr Leila Mansoor weighs in.
Watch video
Credit: An interview by The Lasker Foundation with CAPRISA Associate Scientific Director, Professor Quarraisha Abdool Karim on, "Partnerships, Partnerships, Partnerships.
Watch video